University of Arkansas
Fayetteville, Arkansas, 72704, United States
NCT Number: NCT03602144
One in every three children ages 2-19 years is overweight or obese. Although multifactorial in nature, obesity is primarily attributed to a mismatch between energy intake and energy expenditure (EE). Daily EE (DEE) can be partitioned between resting metabolic rate (RMR), EE associated with physical activity, and the thermic effect of food (TEF). RMR corresponds to the energy needed to sustain the body functions at rest and is also related to body composition (i.e., ratio of skeletal muscle mass to fat mass). Skeletal muscle mass is a large contributor to RMR; the more skeletal muscle mass, the higher the RMR (i.e., more energy expended at rest). In addition, muscle plays a central role in whole body protein metabolism and disrupted muscle metabolism is associated with the development of many common chronic diseases associated with obesity such as type 2 diabetes and cardiovascular disease. Although the contribution of disrupted muscle metabolism to chronic disease is well-established in older adults, the potential impact in children is unknown. The overall objective for this primary project application is to determine the role of breakfast protein consumption in improving energy metabolism, energy balance and skeletal muscle health in obese, school-aged children.
Looking for future studies?
Notify Me7 year–14 year
All sexes
Interventional
Not applicable
Fayetteville, Arkansas, 72704, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive a carbohydrate-based breakfast beverage everyone morning for 42 days.
Participants will receive a protein-based breakfast beverage everyone morning for 42 days.
Time frame: WBEE will be measured as the change between WBEE during day 1 and day 42 of the intervention.
WBEE will be measured using doubly labeled water.
Time frame: VAS will be measured on day 1 and day 42.
Appetite response to test beverages will be measured using visual analog scales. Appetite and palatability were assessed using a traditional 100-mm visual analog scale (VAS) [33] with opposing anchors (e.g., "extremely hungry" or "not hungry at all") at time points 0, 15, 30, 60, 90, and 120 min. Questions consisted of: "how hungry do you feel at this moment", "how full do you feel at this moment", "how strong is your desire to eat this moment" and "how much food do you think you can eat at this moment". A higher number is associated with increased hunger.
Time frame: Glycemic response will be measured on day 1 and day 42.
Glucose and insulin will be measured using commercially available kits.
Time frame: Change in muscle mass will be determined by the difference in muscle mass between day 1 and day 42.
Muscle mass will be measured using stable isotope-labeled creatine.
Time frame: FSR will be determined as the change between baseline (day 0) and day 42.
FSR will be measured using deuterated water and markers of muscle health in plasma.
Time frame: Change in WPT will be determined by the difference in WPT between day 1 and day 42.
WPT will be measured via stable isotope-labeled nitrogen.
Time frame: Change in REE will be determined by the difference in REE between day 1 and day 42.
REE will be measured using indirect calorimetry.
Time frame: Change in body composition will be determined by the difference in body composition between day 1 and day 42.
Body composition will be measured via dual x-ray absorptiometry.
University of Arkansas, Fayetteville
Other
Breakfast, Energy Metabolism, and Skeletal Muscle Health in Obese Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05163587
Blood Glucose, High, Body Composition
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05589129
Athletic Performance, Body Weight
Salt Lake City, Utah, United States
View Trial DetailsNCT05981508
Behavior, Behavior, Animal
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06564753
Body Weight, Body Weight Changes
Camperdown, New South Wales, Australia
View Trial Details